Physician profile
William D Mayer
NPI 1841221686
$20,344.12
in general payments reported to CMS, 2019-2025
28 companies · $950 in 2025
The $950 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,418 · 2020: $722 · 2021: $7,796 · 2022: $2,859 · 2023: $2,454 · 2024: $4,145 · 2025: $950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,676 · Travel and Lodging: $1,858 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,675.98 |
| Travel and Lodging | $1,858.33 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,634.44 | 2019-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $2,333.83 | 2020-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $1,882.71 | 2021-2025 | Ligasure, V-Loc 180, Signia |
| Stryker Corporation | $1,340.33 | 2019-2023 | Spy-Phi System |
| Davol INC. | $1,043.17 | 2019-2024 | Phasix Mesh, Arista Ah Flexitip, Bard 3dmax Mesh |
| Integra Lifesciences Corporation | $931.90 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $776.78 | 2019-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Allergan, INC. | $477.35 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $442.14 | 2020-2023 | Gattex |
| Covidien LP | $432.90 | 2019-2020 | |
| Conmed Corporation | $375.21 | 2019-2025 | Airseal |
| Ethicon US, LLC | $117.90 | 2024-2025 | Stratafix, Endopath |
| Becton, Dickinson and Company | $98.45 | 2022 | |
| Shire North American Group INC | $63.80 | 2019 | |
| Dilon Technologies, INC. | $58.64 | 2025 | Hemoblast Bellows |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $41.26 | 2019-2024 | Gore Enform Preperitoneal Biomaterial |
| Mimedx Group, INC. | $37.11 | 2025 | |
| Innocoll Pharmaceuticals Limited | $34.47 | 2021 | |
| Abbvie INC. | $34.10 | 2021 | |
| Elucent Medical | $31.24 | 2025 | |
| Boston Scientific Corporation | $27.60 | 2025 | Spyglass Discover |
| Pacira Pharmaceuticals Incorporated | $26.89 | 2020-2021 | |
| Cook Medical LLC | $25.47 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $20.81 | 2020 | |
| Acell, INC. | $17.03 | 2019 | |
| Innovation Technologies INC | $13.65 | 2023 | Irrisept |
| Bolder Surgical LLC | $13.07 | 2019 | |
| Coopersurgical, INC. | $11.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.